Tenderwize
Zurück zur Suche

Open-house rebate agreement for therapy allergens

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Dec 03, 2027 · 462 days left·Open·Supplies·Framework
Registrieren zum SpeichernOpen documents
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Therapie-Allergene, ATC V01AA05

55/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Warum diese Bewertung?

Chance

55 / 100

Komplexität

48 / 100

Risikofaktoren

The notice uses an open-procedure form but states that the arrangement is an open-house model outside procurement law...

To obtain contract start on the next month start, complete and correct documents must be received by the 3rd of the mon...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jan 2028
  • Non-exclusive rebate agreements for pharmaceutical products concerning therapy allergens, ATC V01AA05.
  • Open-house model with identical, non-individually negotiable contract terms for all eligible pharmaceutical companies.
Vollständige Zusammenfassung anzeigen

Open-house supply arrangement for pharmaceutical products (therapy allergens, ATC V01AA05) led by AOK Bayern. The model is explicitly described as non-competitive and open to all interested pharmaceutical companies that meet the stated suitability requirement. No contract value is provided. Submission is possible electronically via DTVP with a qualified electronic signature or in paper form in duplicate originals; German language is required, and non-German documents must be submitted with a German translation.

Risiken

The notice uses an open-procedure form but states that the arrangement is an open-house model outside procurement law...

To obtain contract start on the next month start, complete and correct documents must be received by the 3rd of the mon...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • Submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Submit the completed and signed contract and the completed and signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Auftraggeber

Ort

München, DEU

Website

www.aok.de

Auftraggeberprofil

Profil öffnen

Kennung

DE811695320

Tätigkeit

Health

Lose (1)

LOT-0001

Open-house rebate agreement for therapy allergens

Open-house non-exclusive rebate agreement for therapy allergens, ATC V01AA05. The lot is described as a supplies contract and the contract conditions are fixed in advance. Place of performance is Germany, region DE212 (Bavaria/Munich area in the notice metadata).

SuppliesFrameworkEU fundedElectronic submission

Ort

DE212, Germany

Dauer

Jan 2026 - Jan 2028

Kategorie

Pharmaceutical products

Frist

Deadline Dec 03, 2027

Vergabedetails

Veröffentlichungsdatum
14 Dec 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
831006-2025

Dokumente (2)

Vergabedokument 1Einreichungsportal 1

Ähnliche Ausschreibungen

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30